Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Angiographiesysteme

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Dronedarone (Atc Code According to Who: C01bd07)

Circular Protective Aprons as Service Sll763

Order Announcement - Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Teriparatide and the Trade Name Forsteo / Teriparatid Heumann

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion as Part of the So-Called Open House Procedure.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So-Called Open House Procedure.

Conclusion of a Framework Agreement for the Supply of Indication Measures in the Years 2024-2026

Contract Announcement - Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Teriparatide and the Trade Name Livogiva (R)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion as Part of the So-Called Open House Procedure.

Open House Contract for the Supply of Prescribeable Medical Devices Within the Meaning of Section 31 Sgb V - Bandages and other Wound Treatment Products Prescribed for Individual Patients